Evidence map›Paper›PMID 28428837›Full record

ArticleCell & bioscience2017

Min Zhou, Herui Wang, Hui Ren, Rui Jiang, Chi Zhang, Xiaohui Wu, Gezhi Xu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell & bioscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Min Zhou *Department of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, 200031 China.
Herui Wang *State Key Laboratory of Genetic Engineering and National Center for International Research of Development and Disease, Institute of Developmental Biology and Molecular Medicine, Innovation Center of Genetics and Development, School of Life Sciences, Fudan University, Shanghai, 200433 China.
Hui RenDepartment of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, 200031 China.
Rui JiangDepartment of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, 200031 China.
Chi ZhangState Key Laboratory of Genetic Engineering and National Center for International Research of Development and Disease, Institute of Developmental Biology and Molecular Medicine, Innovation Center of Genetics and Development, School of Life Sciences, Fudan University, Shanghai, 200433 China.
Xiaohui WuState Key Laboratory of Genetic Engineering and National Center for International Research of Development and Disease, Institute of Developmental Biology and Molecular Medicine, Innovation Center of Genetics and Development, School of Life Sciences, Fudan University, Shanghai, 200433 China.
Gezhi XuDepartment of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, 200031 China.ORCID 0000-0001-8441-9690
Fudan University · CNNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPersistent fetal vasculature (PFV) is a congenital developmental anomaly of the eye that accounts for about 5% of childhood blindness. The molecular mechanism of PFV remains unclear. As a glycosyltransferase of α-dystroglycan,

resultsIn this paper, we report that a novel

conclusions

Indexed as

Inner limiting membrane (ILM)LargePersistent fetal vasculature (PFV)Retinal astrocytes

Identifiers

PMID28428837
PMCPMC5392960
OpenAlexW2607323987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.